theheart.org : CME programs

Acute Coronary Syndromes

Best Practices in STEMI Management: The Crossroads of Bleeding and Outcomes

Feb 3, 2010 10:49 EST

Dr. Gabriel Steg introduces a discussion between Drs. Anthony Gershlick and Martial Hamon on achieving a balance between favorable outcomes and reducing bleeding in STEMI patients.

Thrombosis

Best practices in VTE prophylaxis: apply the guidelines in patients with cancer

Jan 29, 2010 14:06 EST

Dr. Khorana summarizes the risk factors for VTE in patients with cancer and describes the current strategies for prophylaxis.

Hypertension

Perspectives on the 4th World Symposium on Pulmonary Hypertension

Jan 29, 2010 10:28 EST

Join Dr. Frantz as he reviews and provides his expert perspectives on the Dana Point classification and treatment guidelines for PAH.

Arrhythmia/EP

Cardiac Resynchronization Therapy: Do Recent Data Warrant a Change in the Guidelines?

Jan 28, 2010 16:24 EST

Join Drs. Prystowsky and Wilber as they discuss the results of pivotal cardiac resynchronization therapy trials in heart failure and their potential impact on the current treatment paradigm and guidelines.

Arrhythmia/EP

Risk Stratification in HF and CRT: How Do We Reconcile LV Ejection Fraction, QRS Duration, and NYHA Class?

Jan 27, 2010 10:59 EST

Join Drs. Marchlinski, Bax, and Estes for a discussion on recent CRT-D trials, the impact of therapy in early-stage HF patients, and how LVEF, QRS duration, and NYHA class may guide treatment.

Acute Coronary Syndromes

Antiplatelets in PCI: Doses and Choices

Jan 21, 2010 13:36 EST

Recent data on aspirin and clopidogrel dosing in PCI have left many confused. Dr. Ohman navigates through the data with Drs. Gurbel and Storey.

Arrhythmia/EP

Contemporary Management of Arrhythmia: Practice-Based Approaches

Jan 20, 2010 13:58 EST

Advances have improved the ability to diagnose, prevent, and treat cardiac arrhythmias and associated conditions. Learn about ongoing improvements in arrhythmia management from a stellar Mayo Clinic faculty.

Clinical cardiology

Optimizing Outcomes in Ischemic Heart Disease Management: Issues and Answers

Jan 19, 2010 09:39 EST

Explore key issues in ischemic heart disease, including accurate diagnosis, risk stratification, and data involving new antianginal therapies.

Acute Coronary Syndromes

Antiplatelet Therapy for Atherothrombotic Disease: Taking the Next Steps

1 COMMENT - Jan 4, 2010 14:37 EST

Examine current perspectives in antiplatelet therapy on emerging agents vs current therapy, and review data from recently completed clinical trials.

Prevention

Managing Dysglycemia in Cardiovascular Disease: Preventing Future Events

Dec 29, 2009 15:48 EST

Little success has been realized in achieving target levels for glycemic control, lipids, and blood pressure, as a result the number of patients with diabetes in the U.S. with these risk factors has increased. Drs. Davidson, Blumenthal, and Svec discuss appropriate treatments to guide the physician in the prevention of CVD.

Thrombosis

Preventing Symptomatic, Recurrent Deep Vein Thrombosis or Pulmonary Embolism: The Need for Long-Term Thromboprophylaxis

Dec 23, 2009 11:49 EST

Join Dr. Graham Turpie as he discusses exciting new data on novel oral anticoagulation therapy released at ASH.

Arrhythmia/EP

Advances in Cardiac Resynchronization Therapy and Left Ventricular Reverse Remodeling in Heart Failure

Dec 22, 2009 10:19 EST

Join Drs. Fonarow, Gold, and Klein as they discuss recent clinical trial data in cardiac resynchronization therapy and left ventricular reverse remodeling in early-stage heart failure patients.

Interventional/Surgery

DES Comparisons: Insights From Late-term Follow-up

1 COMMENT - Dec 21, 2009 11:25 EST

COMPARE, ENDEAVOR IV, SIRTAX-LATE, SPRIT IV -- given the abundance of data comparing the various DES are there any patterns emerging? Dr. King leads a panel discussion with Drs. Cohen and Williams.

Imaging

Trials and Tribulations: Debating Controversial Topics in Cardiovascular Disease

Dec 21, 2009 09:48 EST

Fellows from The Mayo Clinic, Duke University, and The Cleveland Clinic discuss challenging cases with their mentors.

Acute Coronary Syndromes

Stent Thrombosis: A Case-Based Discussion

Dec 17, 2009 14:59 EST

Dr. Holmvang presents 2 cases of stent thrombosis to Dr. Kristensen outlining risk factors and potential strategies to prevent this catastrophic event.

Arrhythmia/EP

Risk Stratification in Hypertrophic Cardiomyopathy: ICD Therapy

1 COMMENT - Dec 17, 2009 13:30 EST

Join Drs. Prystowsky and Estes as they discuss risk stratification of patients with hypertrophic cardiomyopathy and strategies for implementing implantable device therapy.

Arrhythmia/EP

Pharmacologic Advances in Atrial Fibrillation: Achieving Optimal Antiarrhythmic and Cardiovascular Outcomes

2 COMMENTS - Dec 17, 2009 10:15 EST

Join Drs. Camm, Freemantle, and Connolly as they discuss a meta-analysis of antiarrhythmic agents and their impact on cardiovascular outcomes.

Hypertension

Stop Hypertension Now! Recognize and Manage Your High-Risk Patients

Dec 17, 2009 09:30 EST

Hypertension affects approximately 73 million adults in the U.S. and is one of the most important risk factors for cardiovascular and renal diseases. Dr. Kountz will focus on current hypertension treatment disparities and high-risk patients while providing a thorough exploration of guideline-based management strategies.

Acute Coronary Syndromes

Antiplatelet Therapy in ACS: Copenhagen Masterclass Roundtable

Dec 16, 2009 16:10 EST

What are the implications of recent data on the antiplatelet agents in ACS for Europe? Recorded at the 2009 ACS Masterclass in Copenhagen, Denmark, Dr. Clemmensen leads a roundtable discussion with Drs. Collet, Kristensen, and Schühlen.

Hypertension

The Prevention of Microalbuminuria in Diabetes

1 COMMENT - Dec 16, 2009 12:00 EST

Drs. Izzo and Ruilope discuss the importance of RAS inhibition in controlling hypertension to prevent or delay the development of MA in patients with diabetes.

Hypertension

Pulmonary Complications in Connective Tissue Disease

Dec 16, 2009 10:29 EST

Join Drs. McLaughlin and Khanna as they discuss the diagnostic challenges and treatment options for PAH in patients with CTD.

Acute Coronary Syndromes

Thrombosis: Describing the Clinical Link Between the Coagulation Cascade and Platelet Function

2 COMMENTS - Dec 14, 2009 17:21 EST

Join Drs. Alexander, Becker, and Weitz for a discussion on the coagulation cascade, its link to platelet function, and the risk/benefit and clinical utility of agents that target the coagulation cascade and platelet receptors.

Acute Coronary Syndromes

Translating Evidence From Trials With Antiplatelet Agents Into Clinical Practice

Dec 8, 2009 10:03 EST

Recently reported and new trials of antiplatelet therapy continue to redefine optimal management strategies for patients with atherothrombotic disease and patients with atrial fibrillation. Drs. Harrington, Angiolillo, Bhatt, Connolly, Mehta, and Simon discuss guidelines? recommendations for the use of antiplatelet therapies and the potential impact of emerging data regarding currently used and novel antiplatelet agents.

Arrhythmia/EP

Improving the Day-to-Day Management of Patients with Atrial Fibrillation

Dec 7, 2009 15:02 EST

Join Drs. Prystowsky, Camm, and Pepine for a discussion on late-breaking results from the RecordAF registry presented at AHA 2009.

Acute Coronary Syndromes

Antiplatelet Therapy in ACS: Evidence-Based Medicine in Real-World Practice

1 COMMENT - Dec 7, 2009 12:46 EST

With the approval of a third-generation thienopyridine, new clinical trial data on novel agents, and the dosing of clopidogrel, Dr. Berger asks Dr. Cohen how he has incorporated this information into his practice.